Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Disaggregation of Revenue

Revenues for the three months ended March 31, 2020 and 2019 were as follows:

	Three Months Ended March 31,
	2020		2019
	(Amounts in thousands)
Product revenue	$	76,060	$	60,612
Royalty and other income		30		22
Total revenue	$	76,090	$	60,634

Revenue from Significant Customers

Revenue from significant customers that represent 10% or more of the Company’s total revenue is as follows:

	Three Months Ended March 31,
	2020		2019
	(Amounts in thousands)
MilliporeSigma	$	10,873	$	9,407
GE Healthcare		N/A	$	7,666

Summary of Receivables and Deferred Revenue from Contracts with Customers

The following table provides information about receivables and deferred revenues from contracts with customers as of March 31, 2020 (amounts in thousands): 

	2020
Balances from contracts with customers only:
Accounts receivable	$	44,726
Deferred revenue (included in accrued liabilities in the consolidated balance sheets)		6,305
Revenue recognized for the three months ended March 31, 2020 relating to:
The beginning deferred revenue balance	$	1,911
Changes in pricing related to products or services satisfied in previous periods		—